RSS

TESARO

Pharmaceutical giant GSK has announced a major acquisition of the biotech company Tesaro to help bolster its oncology pipeline. Read more

News

Biopharmaceutical company, Tesaro, has revealed that the European Commission has approved its monotherapy for the maintenance treatment of women with recurrent ovarian cancer. Read more

News

Small molecule pharmaceutical development and manufacturing capability and technology platform company, STA Pharmaceutical, has entered into a five-year supply agreement with oncology-focused biopharma company, TESARO. Read more

News